Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53.
about
Transcriptional Targeting in Cancer Gene TherapySelective killing of Smad4-negative tumor cells via a designed repressor strategyNotch1-expressing cells are indispensable for prostatic branching morphogenesis during development and re-growth following castration and androgen replacement.Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70.
P2860
Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tumour-specific therapeutic ad ...... althy cells by endogenous p53.
@en
Tumour-specific therapeutic ad ...... althy cells by endogenous p53.
@nl
type
label
Tumour-specific therapeutic ad ...... althy cells by endogenous p53.
@en
Tumour-specific therapeutic ad ...... althy cells by endogenous p53.
@nl
prefLabel
Tumour-specific therapeutic ad ...... althy cells by endogenous p53.
@en
Tumour-specific therapeutic ad ...... althy cells by endogenous p53.
@nl
P2093
P2860
P356
P1433
P1476
Tumour-specific therapeutic ad ...... ealthy cells by endogenous p53
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301403
P50
P577
2001-02-01T00:00:00Z
P5875
P6179
1021686868